19Dec
As its COVID-19 Vaccine Nears Finalization, AstraZeneca Announces Deal to Buy Alexion for $39 Billion
AstraZeneca, the British-Swedish multinational pharmaceutical company currently collaborating with the University of Oxford on a COVID-19 vaccine, will purchase Alexion Pharmaceuticals for $39 billion. The transaction, which awaits approval by shareholders and regulators, is the largest purchase by a health care company this year and is expected to close in the third quarter of 2021. Alexion was founded in 1992 and is headquartered in Boston but has a global presence. It is known for its...
By:
Rothwell, Figg, Ernst & Manbeck, P.C.
Related
This year has seen states enact a litany of laws aimed at addressing pay equity issues, chief among ...
Read More >
Focus On Whistleblower Protections - Avoiding and Defending Whistleblower Claims - Defending Sarba...
Read More >
Further to our February 2020 client alert on Oman's new Foreign Capital Investment Law (FCIL), Minis...
Read More >
Things That 401(k) Plan Sponsors Are Supposed To Do, But Aren't Doing Anyway. So many things they s...
Read More >
If so, you should be on alert about California Assembly Bill 5 (AB5), a bill based on the California...
Read More >
Seyfarth Synopsis: It should be clear to all that the NLRB has taken significant steps to restore th...
Read More >